Please try another search
| YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
|---|---|---|---|---|---|---|
| Growth of 1000 | 1155 | 1022 | 1089 | 1222 | 1072 | - |
| Fund Return | 15.45% | 2.18% | 8.89% | 6.92% | 1.4% | - |
| Place in category | 1379 | 1749 | 1107 | 940 | 1072 | - |
| % in Category | 62 | 73 | 54 | 59 | 82 | - |
| Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
|---|---|---|---|---|---|---|
| Equity World Technology Classic US | 4.43B | 10.53 | 18.98 | 16.89 | ||
| Equity World Technology Classic USu | 4.43B | 10.53 | 18.98 | 16.89 | ||
| LU1596574779 | 3.05B | -3.40 | 5.95 | - | ||
| LU1543694498 | 3.05B | -3.54 | 5.89 | - | ||
| BNP Paribas Aqua N Cap USD | 3.04B | 0.02 | 3.33 | 7.93 |
| Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
|---|---|---|---|---|---|---|
| GS S GS Europe CORE Equity Portfolu | 3.98B | 25.37 | 19.33 | 7.33 | ||
| Europe Equity Plus Fund A perf acc | 3.26B | 27.74 | 22.05 | 7.59 | ||
| JPEurope Equity Plus Fund C perf ac | 3.26B | 12.33 | 11.13 | 7.14 | ||
| JPMorgan InVs Euro SelectEqD AccUSD | 2.28B | 22.88 | 16.21 | 5.06 | ||
| JPMorgan InVs Euro SelectEqA AccUSD | 2.28B | 23.34 | 17.10 | 5.85 |
| Name | ISIN | Weight % | Last | Change % | |
|---|---|---|---|---|---|
| Sanofi | FR0000120578 | 4.46 | 80.93 | +0.11% | |
| Royal Dutch Shell PLC Class A | GB00B03MLX29 | 4.27 | - | - | |
| GlaxoSmithKline PLC | GB0009252882 | 4.23 | - | - | |
| Experian | GB00B19NLV48 | 3.65 | 3,804.0 | -1.45% | |
| EssilorLuxottica | FR0000121667 | 3.19 | 252.90 | +0.28% |
| Type | Daily | Weekly | Monthly |
|---|---|---|---|
| Moving Averages | Buy | Buy | Buy |
| Technical Indicators | Neutral | Strong Buy | Strong Buy |
| Summary | Neutral | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review